The red ink used in the study contains a chemical (2-anisidine) that’s not allowed in human tattoos because it might cause cancer.
Scientific Claim
The potential carcinogen 2-anisidine is present in a commonly used red tattoo ink that is banned for human use due to safety concerns.
Original Statement
“This often used ink is banned for use on humans because of high content of the potential carcinogen 2-anisidine.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design cannot support claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The claim reports a regulatory fact cited by the authors, not a result of their experiment. It is appropriately stated as a known regulatory status, not a study finding.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Cohort StudyLevel 2bWhether human tattoo recipients with 2-anisidine-containing ink have higher skin cancer incidence.
Whether human tattoo recipients with 2-anisidine-containing ink have higher skin cancer incidence.
What This Would Prove
Whether human tattoo recipients with 2-anisidine-containing ink have higher skin cancer incidence.
Ideal Study Design
A prospective cohort of 10,000+ humans with red tattoos containing 2-anisidine (verified by chemical analysis) and 10,000+ controls without, followed for 20 years with annual skin exams and biopsy confirmation of SCC.
Limitation: Extremely costly and ethically challenging; confounding by UV exposure is unavoidable.
Case-Control StudyLevel 2bWhether 2-anisidine-containing tattoos are more common in skin cancer patients than controls.
Whether 2-anisidine-containing tattoos are more common in skin cancer patients than controls.
What This Would Prove
Whether 2-anisidine-containing tattoos are more common in skin cancer patients than controls.
Ideal Study Design
A matched case-control study of 500+ skin cancer patients and 500+ healthy controls, with tattoo ink samples analyzed for 2-anisidine content via mass spectrometry and exposure history collected.
Limitation: Relies on recall and ink availability for analysis; cannot establish temporal sequence.
In Vitro StudyLevel 5Whether 2-anisidine causes DNA damage in human keratinocytes.
Whether 2-anisidine causes DNA damage in human keratinocytes.
What This Would Prove
Whether 2-anisidine causes DNA damage in human keratinocytes.
Ideal Study Design
Exposure of primary human keratinocytes to 2-anisidine (1–100 µM) for 48 hours, measuring DNA adducts (32P-postlabeling), oxidative stress (8-OHdG), and gene mutations (whole-exome sequencing).
Limitation: Does not reflect in vivo metabolism or immune response.
Evidence from Studies
Supporting (1)
Red tattoos, ultraviolet radiation and skin cancer in mice
The study used a red tattoo ink that scientists already know is banned for people because it contains a harmful chemical called 2-anisidine — and they confirmed it’s there. So yes, the claim is true.